PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
EWTX vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between EWTX and SPY is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

EWTX vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Edgewise Therapeutics Inc (EWTX) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%80.00%SeptemberOctoberNovemberDecember2025February
24.79%
9.78%
EWTX
SPY

Key characteristics

Sharpe Ratio

EWTX:

0.56

SPY:

1.91

Sortino Ratio

EWTX:

1.63

SPY:

2.57

Omega Ratio

EWTX:

1.19

SPY:

1.35

Calmar Ratio

EWTX:

0.79

SPY:

2.88

Martin Ratio

EWTX:

2.79

SPY:

11.96

Ulcer Index

EWTX:

16.37%

SPY:

2.03%

Daily Std Dev

EWTX:

81.47%

SPY:

12.68%

Max Drawdown

EWTX:

-84.69%

SPY:

-55.19%

Current Drawdown

EWTX:

-28.65%

SPY:

0.00%

Returns By Period

In the year-to-date period, EWTX achieves a -2.13% return, which is significantly lower than SPY's 4.34% return.


EWTX

YTD

-2.13%

1M

-0.50%

6M

32.51%

1Y

50.43%

5Y*

N/A

10Y*

N/A

SPY

YTD

4.34%

1M

2.33%

6M

10.15%

1Y

23.99%

5Y*

14.44%

10Y*

13.21%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

EWTX vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EWTX
The Risk-Adjusted Performance Rank of EWTX is 6969
Overall Rank
The Sharpe Ratio Rank of EWTX is 6565
Sharpe Ratio Rank
The Sortino Ratio Rank of EWTX is 7171
Sortino Ratio Rank
The Omega Ratio Rank of EWTX is 6767
Omega Ratio Rank
The Calmar Ratio Rank of EWTX is 7373
Calmar Ratio Rank
The Martin Ratio Rank of EWTX is 7070
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 7878
Overall Rank
The Sharpe Ratio Rank of SPY is 7878
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 7474
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 7777
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 7878
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 8181
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

EWTX vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Edgewise Therapeutics Inc (EWTX) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for EWTX, currently valued at 0.56, compared to the broader market-2.000.002.004.000.561.91
The chart of Sortino ratio for EWTX, currently valued at 1.63, compared to the broader market-6.00-4.00-2.000.002.004.006.001.632.57
The chart of Omega ratio for EWTX, currently valued at 1.19, compared to the broader market0.501.001.502.001.191.35
The chart of Calmar ratio for EWTX, currently valued at 0.79, compared to the broader market0.002.004.006.000.792.88
The chart of Martin ratio for EWTX, currently valued at 2.79, compared to the broader market0.0010.0020.0030.002.7911.96
EWTX
SPY

The current EWTX Sharpe Ratio is 0.56, which is lower than the SPY Sharpe Ratio of 1.91. The chart below compares the historical Sharpe Ratios of EWTX and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.006.00SeptemberOctoberNovemberDecember2025February
0.56
1.91
EWTX
SPY

Dividends

EWTX vs. SPY - Dividend Comparison

EWTX has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.16%.


TTM20242023202220212020201920182017201620152014
EWTX
Edgewise Therapeutics Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
1.16%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

EWTX vs. SPY - Drawdown Comparison

The maximum EWTX drawdown since its inception was -84.69%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for EWTX and SPY. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-28.65%
0
EWTX
SPY

Volatility

EWTX vs. SPY - Volatility Comparison

Edgewise Therapeutics Inc (EWTX) has a higher volatility of 13.97% compared to SPDR S&P 500 ETF (SPY) at 3.13%. This indicates that EWTX's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2025February
13.97%
3.13%
EWTX
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab